跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 135 条关于
“Clairity”
全部
135
临床试验
79
药物
3
机构
9
资讯
44
10个月前
Clairity Secures $43M Series B to Commercialize First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
9个月前
Clairity, Myriad Genetics, and MagView Launch First Integrated AI-Genetic Risk Platform for Breast Cancer Screening
去年
FDA Grants First-Ever Authorization for AI Platform to Predict Breast Cancer Risk from Mammograms
去年
Clarity Pharmaceuticals Initiates Phase I/IIa Trial of 64Cu-SAR-bisPSMA for Metastatic Castration-Resistant Prostate Cancer
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA Gain FDA Fast Track Designations for Prostate Cancer
去年
Sarepta's Elevidys Data Leaves Duchenne Community Seeking More Clarity
去年
Clarity Pharma Shares Surge on Production Deal with Nucleus Radiopharma for Prostate Cancer Drug
去年
Clarity Pharmaceuticals and Nucleus RadioPharma Partner to Scale Up Production of 67Cu-SAR-bisPSMA for Prostate Cancer Treatment
去年
FDA Fast-Tracks Clarity Pharmaceuticals' Novel Prostate Cancer Imaging Agent
2年前
Clarity Pharmaceuticals' 67Cu-SAR-bisPSMA Shows Promise in mCRPC Trial
第 1 页,共 5 页
上一页
下一页